Condition

Atrial Fibrillation (1)

Chronic Lymphocytic Leukemia (1)

Mediastinal Grey Zone Lymphoma (1)

Non-Hodgkin's Lymphoma (1)

Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (1)

Small Lymphocytic Lymphoma (1)

To Characterize and Compare Clinical, Pathological and Molecular Features (1)

Overall Status

Completed (3)

Enrolling by invitation (1)

Recruiting (1)

Phase

n/a (1)

phase 1 (1)

phase 3 (1)

Sponsor

Hospices Civils de Lyon (2)

Aptose Biosciences Inc. (1)

Astellas Pharma Inc (1)

The First Affiliated Hospital of Soochow University (1)

Collaborator

Advanz Pharma (1)

Study Documents

Intervention Type

drug (3)

other (1)

Funder Type

Other (3)

Industry (2)

Study Type

Interventional (3)

Observational (2)

GZL

Showing 1 - 5 of 5

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Relapsed or Refractory B-cell Non-Hodgkin Lymphoma Trial in Suzhou (Obinutuzumab, Zanubrutinib, Lenalidomide)

Enrolling by invitation

Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

Obinutuzumab
+6 more

Suzhou, Jiangsu, China

the First Affiliated Hospital of Soochow University

Mar 22, 2023

EBV-associated Diffuse Large B Cell Lymphoma

Completed

To Characterize and Compare Clinical, Pathological and Molecular Features

clinical and pathological data EBV-related GZL and DLBCL

Lyon, Pierre Bénite, France

HCL

Feb 21, 2019

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Non-Hodgkin's Lymphoma Trial in United States (CG-806)

Recruiting

Chronic Lymphocytic Leukemia
+2 more

CG-806

Phoenix, Arizona
+30 more

Mar 28, 2022

Mediastinal Grey Zone Lymphoma From the LYSA

Completed

Mediastinal Grey Zone Lymphoma

Pierre Bénite, Rhône Alpes, France

Centre hospitalier Lyon sud

Jan 27, 2017

Atrial Fibrillation Trial in Worldwide (RSD1235)

Completed

Atrial Fibrillation

RSD1235

Huntsville, Alabama
+39 more

Apr 1, 2008